1. Home
  2. PRTA vs LOCO Comparison

PRTA vs LOCO Comparison

Compare PRTA & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • LOCO
  • Stock Information
  • Founded
  • PRTA 2012
  • LOCO 1980
  • Country
  • PRTA Ireland
  • LOCO United States
  • Employees
  • PRTA N/A
  • LOCO N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • LOCO Restaurants
  • Sector
  • PRTA Health Care
  • LOCO Consumer Discretionary
  • Exchange
  • PRTA Nasdaq
  • LOCO Nasdaq
  • Market Cap
  • PRTA 346.4M
  • LOCO 331.5M
  • IPO Year
  • PRTA N/A
  • LOCO 2014
  • Fundamental
  • Price
  • PRTA $6.41
  • LOCO $10.96
  • Analyst Decision
  • PRTA Buy
  • LOCO Buy
  • Analyst Count
  • PRTA 9
  • LOCO 3
  • Target Price
  • PRTA $27.67
  • LOCO $15.50
  • AVG Volume (30 Days)
  • PRTA 1.7M
  • LOCO 354.5K
  • Earning Date
  • PRTA 08-07-2025
  • LOCO 07-31-2025
  • Dividend Yield
  • PRTA N/A
  • LOCO N/A
  • EPS Growth
  • PRTA N/A
  • LOCO 6.54
  • EPS
  • PRTA N/A
  • LOCO 0.86
  • Revenue
  • PRTA $137,935,000.00
  • LOCO $476,032,000.00
  • Revenue This Year
  • PRTA N/A
  • LOCO $6.28
  • Revenue Next Year
  • PRTA $122.02
  • LOCO $1.14
  • P/E Ratio
  • PRTA N/A
  • LOCO $12.77
  • Revenue Growth
  • PRTA 54.55
  • LOCO 1.22
  • 52 Week Low
  • PRTA $4.32
  • LOCO $8.29
  • 52 Week High
  • PRTA $25.42
  • LOCO $14.25
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 57.61
  • LOCO 57.24
  • Support Level
  • PRTA $5.96
  • LOCO $10.94
  • Resistance Level
  • PRTA $6.77
  • LOCO $11.55
  • Average True Range (ATR)
  • PRTA 0.36
  • LOCO 0.40
  • MACD
  • PRTA 0.14
  • LOCO -0.02
  • Stochastic Oscillator
  • PRTA 75.80
  • LOCO 67.74

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About LOCO El Pollo Loco Holdings Inc.

El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.

Share on Social Networks: